A detailed history of Russell Investments Group, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 662,518 shares of LLY stock, worth $521 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
662,518
Previous 578,208 14.58%
Holding current value
$521 Million
Previous $523 Million 12.12%
% of portfolio
0.88%
Previous 0.87%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $65.1 Million - $80.9 Million
84,310 Added 14.58%
662,518 $587 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $5.66 Million - $7.09 Million
7,802 Added 1.37%
578,208 $523 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $31.7 Million - $42.5 Million
53,602 Added 10.37%
570,406 $444 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $4.36 Million - $5.14 Million
8,309 Added 1.63%
516,804 $301 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $14.5 Million - $20 Million
33,377 Added 7.02%
508,495 $273 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $13.6 Million - $18.2 Million
-38,910 Reduced 7.57%
475,118 $223 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $16.4 Million - $19.3 Million
52,836 Added 11.46%
514,028 $177 Million
Q4 2022

Feb 08, 2023

BUY
$321.55 - $374.67 $5.86 Million - $6.82 Million
18,214 Added 4.11%
461,192 $169 Million
Q3 2022

Nov 04, 2022

SELL
$296.48 - $337.87 $732,009 - $834,201
-2,469 Reduced 0.55%
442,978 $144 Million
Q2 2022

Jul 29, 2022

BUY
$278.73 - $327.27 $5.79 Million - $6.8 Million
20,790 Added 4.9%
445,447 $144 Million
Q1 2022

May 05, 2022

SELL
$234.69 - $291.66 $7.13 Million - $8.86 Million
-30,380 Reduced 6.68%
424,657 $122 Million
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $11.6 Million - $14.4 Million
51,730 Added 12.83%
455,037 $126 Million
Q3 2021

Nov 08, 2021

BUY
$221.6 - $272.71 $2.49 Million - $3.06 Million
11,226 Added 2.86%
403,307 $93.1 Million
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $3 Million - $3.88 Million
16,627 Added 4.43%
392,081 $90 Million
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $53.8 Million - $69.6 Million
-327,401 Reduced 46.58%
375,454 $70.1 Million
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $110,369 - $146,044
-846 Reduced 0.12%
702,855 $118 Million
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $21.2 Million - $24.6 Million
145,227 Added 26.0%
703,701 $104 Million
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $7.64 Million - $9.19 Million
55,992 Added 11.14%
558,474 $91.5 Million
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $20.2 Million - $24.9 Million
169,278 Added 50.8%
502,482 $69.7 Million
Q4 2019

Jan 29, 2020

BUY
$106.92 - $132.43 $1.1 Million - $1.36 Million
10,264 Added 3.18%
333,204 $43.8 Million
Q3 2019

Nov 01, 2019

SELL
$106.79 - $116.16 $9.41 Million - $10.2 Million
-88,106 Reduced 21.43%
322,940 $36.1 Million
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $5.41 Million - $6.31 Million
-48,814 Reduced 10.61%
411,046 $45.6 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $26.8 Million - $31.5 Million
-240,341 Reduced 34.32%
459,860 $59.6 Million
Q4 2018

Feb 11, 2019

SELL
$105.9 - $118.64 $21.9 Million - $24.5 Million
-206,639 Reduced 22.79%
700,201 $80.8 Million
Q3 2018

Oct 26, 2018

BUY
$85.86 - $107.31 $16.2 Million - $20.2 Million
188,150 Added 26.18%
906,840 $97.2 Million
Q2 2018

Aug 08, 2018

BUY
$75.7 - $86.88 $1.36 Million - $1.56 Million
17,955 Added 2.56%
718,690 $61.4 Million
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $7.49 Million - $8.84 Million
100,928 Added 16.83%
700,735 $54.1 Million
Q4 2017

Feb 06, 2018

SELL
$81.94 - $87.89 $22.8 Million - $24.4 Million
-277,911 Reduced 31.66%
599,807 $51 Million
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $67.6 Million - $75.1 Million
877,718
877,718 $75.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $747B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.